BALANCE SHEET
Akums Drugs & Pharmaceuticals Ltd.
BSE
Jul 16
562.25
+4.70 (+ 0.84%)
Volume
13008
Prev. Close
557.55
Open Price
558.95
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
NSE
Jul 16
561.60
+4.75 (+ 0.85%)
Volume
161500
Prev. Close
556.85
Open Price
556.85
Bid Price(Qty.)
0.00 (0)
Offer Pr.(Qty.)
0.00 (0)
You can view the
Balance Sheet
for the last 5 years.
ISIN No
|
INE09XN01023
|
Market Cap. ( ₹ in Cr. )
|
8839.25
|
P/BV
|
3.12
|
Book Value ( ₹ )
|
180.08
|
BSE Code
|
544222
|
52 Week High/Low ( ₹ )
|
1176/405
|
FV/ML
|
2/1
|
P/E(X)
|
26.14
|
NSE Code
|
AKUMSEQ
|
Book Closure
|
|
EPS ( ₹ )
|
21.49
|
Div Yield (%)
|
0.00
|
(₹ in Crs.)
Months | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
FaceValue | 2.00 | 2.00 | 2.00 |
No. of Equity Shares (in Lacs) | 1573.94 | 1430.64 | 1430.64 |
| | | |
EQUITIES AND LIABILITIES | | | |
SHAREHOLDER'S FUNDS | | | |
Equity Share Capital | 30.62 | 28.61 | 28.61 |
Total Share Capital | 30.62 | 28.61 | 28.61 |
| | | |
Reserves and Surplus | 2274.63 | 115.27 | 282.89 |
Total Reserves and Surplus | 2274.63 | 115.27 | 282.89 |
Total Shareholders Funds | 2305.25 | 143.88 | 311.50 |
| | | |
NON-CURRENT LIABILITIES | | | |
Long Term Borrowings | 0.00 | 15.63 | 21.88 |
Deferred Tax Liabilities [Net] | 7.46 | 10.31 | 0.00 |
Other Long Term Liabilities | 49.96 | 1412.52 | 1056.06 |
Long Term Provisions | 12.93 | 11.35 | 8.21 |
Total Non-Current Liabilities | 70.36 | 1449.81 | 1086.15 |
| | | |
CURRENT LIABILITIES | | | |
Short Term Borrowings | 3.93 | 210.66 | 123.71 |
Trade Payables | 219.56 | 164.91 | 177.97 |
Other Current Liabilities | 80.11 | 120.76 | 189.13 |
Short Term Provisions | 5.71 | 5.40 | 5.75 |
Total Current Liabilities | 309.31 | 501.74 | 496.56 |
| | | |
Total Capital And Liabilities | 2684.91 | 2095.43 | 1894.21 |
| | | |
ASSETS | | | |
NON-CURRENT ASSETS | | | |
Tangible Assets | 334.92 | 295.40 | 251.03 |
Intangible Assets | 2.60 | 3.08 | 2.11 |
Capital Work-In-Progress | 53.71 | 8.57 | 16.13 |
Intangible Assets Under Development | 3.02 | 0.09 | 0.12 |
Other Assets | 18.49 | 18.86 | 19.26 |
Fixed Assets | 412.74 | 326.00 | 288.65 |
Non-Current Investments | 366.01 | 138.92 | 139.16 |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 3.13 |
Long Term Loans And Advances | 1044.34 | 1071.67 | 914.89 |
Other Non-Current Assets | 28.63 | 25.60 | 27.28 |
Total Non-Current Assets | 1851.73 | 1562.18 | 1373.13 |
| | | |
| | | |
CURRENT ASSETS | | | |
Inventories | 201.69 | 161.70 | 197.12 |
Trade Receivables | 206.14 | 233.79 | 256.13 |
Cash And Cash Equivalents | 356.12 | 73.31 | 8.85 |
OtherCurrentAssets | 69.24 | 64.43 | 58.98 |
Total Current Assets | 833.18 | 533.24 | 521.08 |
| | | |
Total Assets | 2684.91 | 2095.43 | 1894.21 |
| | | |
OTHER INFORMATION | | | |
| | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | |
Contingent Liabilities | 31.99 | 126.48 | 199.21 |
| | | |
BONUS DETAILS | | | |
Bonus Equity Share Capital | 14.31 | 14.31 | 14.31 |
| | | |
NON-CURRENT INVESTMENTS | | | |
Non-Current Investments Unquoted Book Value | 366.01 | 138.92 | 139.16 |